JULIE LYNCH: Open Payments
NPI 1477281152 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 44 payments from 9 companies in 2025. Trend: 2023 $512 · 2024 $281 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 14 | $344 |
| Otsuka America Pharmaceutical, Inc. | 9 | $161 |
| E.R. Squibb & Sons, L.L.C. | 10 | $145 |
| Teva Pharmaceuticals USA, Inc. | 4 | $93 |
| Vanda Pharmaceuticals Inc. | 3 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Lundbeck LLC | 1 | $14 |
Products named: ARISTADA, COBENFY, REXULTI, FANAPT, UZEDY, ABILIFY MAINTENA, AUSTEDO XR, CAPLYTA.
Industry payments across MI — which companies pay providers there.
